Cargando…
Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy
Autores principales: | Feng, Jingjing, Shao, Mi, Hu, Yongxian, Huang, He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795291/ https://www.ncbi.nlm.nih.gov/pubmed/35091688 http://dx.doi.org/10.1038/s41409-022-01562-4 |
Ejemplares similares
-
Clarkson’s Disease Episode or Secondary Systemic Capillary Leak-Syndrome: That Is the Question!
por: Pineton de Chambrun, Marc, et al.
Publicado: (2021) -
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
por: Ding, Jing, et al.
Publicado: (2022) -
A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
por: Wang, Yiyun, et al.
Publicado: (2020) -
Recent progress in improving the safety and efficacy of chimeric antigen receptor T cell therapy
por: Yang, Yingying, et al.
Publicado: (2018) -
Toxic epidermal necrosis caused by programmed cell death protein 1 inhibitors in a patient receiving chimeric antigen receptor-T cell therapy
por: Wang, Chengji, et al.
Publicado: (2023)